INTUITAP MEDICAL, INC.

SBIR Phase II: Tactile sensing for spinal-needle placements

INTUITAP MEDICAL, INC. operates in biomedical engineering based in CHICAGO, IL, founded in 2016.

Profile

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to support needs in emergency medicine, neurology, and anesthesiology for a low-cost, non-radiative device that allows for accurate, efficient, and intuitive placement of needles in the spine. By reducing the number of required injection attempts, the device reduces patient pain, number of complications, and the need for radiation. The device could also be employed as a training tool to improve physician skill and familiarity with lumbar punctures, thus reducing errors. While the currently proposed device is limited to use in the lumbar region, future versions will expand its use to other regions on patients’ spine, greatly impacting injections for pain management. In the future, the device can also offer an imaging option for the current blind techniques in other clinical procedures such as joint injections.

This Small Business Innovation Research Phase II project will expand functionality of the first device. A prototype device has been shown to improve the accuracy and efficiency of lumbar punctures. However, in response to clinician needs, the functionality will further be expanded as follows: The first objective adds external needle position tracking by adding full needle insertion and lateral adjustment functionalities to the needle guide. Tracking mechanisms

INTUITAP MEDICAL, INC. is positioned in biomedical engineering, a segment that rewards a clear, focused offering.

The business is associated with CHICAGO, IL.

Its current recorded stage is SBIR Phase II.

Recorded headcount: c_00001_00010 employees.

Public records show total funding of about $1M.

Website: www.intuitapmedical.com